Zydus ties up with Guardant Health to promote cancer tests across India, Nepal
The tests to be promoted include the Guardant360 and Guardant360 TissueNext tests for comprehensive genomic profiling and the Guardant360 Response test for monitoring response to treatment, the drug maker said in a statement.
The companies have inked a co-marketing agreement to jointly promote the Guardant360 portfolio in India and Nepal, representative image, image- Reuters